MAROTTA, Vincenzo
 Distribuzione geografica
Continente #
AS - Asia 4.932
SA - Sud America 362
NA - Nord America 260
EU - Europa 91
AF - Africa 20
OC - Oceania 3
Continente sconosciuto - Info sul continente non disponibili 1
Totale 5.669
Nazione #
HK - Hong Kong 4.463
BR - Brasile 277
US - Stati Uniti d'America 238
VN - Vietnam 196
SG - Singapore 147
CN - Cina 69
AR - Argentina 36
ID - Indonesia 18
EC - Ecuador 17
IT - Italia 17
MX - Messico 14
UA - Ucraina 14
IN - India 13
BD - Bangladesh 12
DE - Germania 12
CO - Colombia 10
PY - Paraguay 10
CL - Cile 6
PL - Polonia 6
RU - Federazione Russa 6
GB - Regno Unito 5
KE - Kenya 5
ZA - Sudafrica 5
FR - Francia 4
IQ - Iraq 4
LT - Lituania 4
RS - Serbia 4
TR - Turchia 4
AT - Austria 3
AU - Australia 2
CA - Canada 2
CR - Costa Rica 2
DO - Repubblica Dominicana 2
EG - Egitto 2
FI - Finlandia 2
IE - Irlanda 2
MA - Marocco 2
NL - Olanda 2
PK - Pakistan 2
RO - Romania 2
TN - Tunisia 2
UY - Uruguay 2
VE - Venezuela 2
AL - Albania 1
AZ - Azerbaigian 1
BO - Bolivia 1
CI - Costa d'Avorio 1
ES - Italia 1
GT - Guatemala 1
HU - Ungheria 1
JP - Giappone 1
KR - Corea 1
LV - Lettonia 1
MK - Macedonia 1
ML - Mali 1
NG - Nigeria 1
NZ - Nuova Zelanda 1
PA - Panama 1
PE - Perù 1
PT - Portogallo 1
SE - Svezia 1
SK - Slovacchia (Repubblica Slovacca) 1
TG - Togo 1
UZ - Uzbekistan 1
XK - ???statistics.table.value.countryCode.XK??? 1
Totale 5.669
Città #
Hong Kong 4.461
Dallas 144
Ho Chi Minh City 75
Singapore 60
Hanoi 44
São Paulo 19
Boardman 16
Rio de Janeiro 11
Da Nang 10
Woodbridge 10
Mexico City 9
Ann Arbor 8
Curitiba 8
Haiphong 8
Thái Bình 7
Biên Hòa 6
Brasília 6
Chandler 6
Guayaquil 6
Jacksonville 6
Quito 6
Buenos Aires 5
Campinas 5
Coimbatore 5
Los Angeles 5
Munich 5
Naples 5
Phủ Lý 5
Asunción 4
Beijing 4
Gdansk 4
Guarulhos 4
Huế 4
Izmir 4
Johannesburg 4
Kyiv 4
Nairobi 4
Nuremberg 4
Porto Alegre 4
Ribeirão Preto 4
Santiago 4
Santiago de Cali 4
Ashburn 3
Baghdad 3
Buffalo 3
Bắc Giang 3
Bắc Ninh 3
Chicago 3
Hải Dương 3
Joinville 3
Manaus 3
Maringá 3
Milan 3
New York 3
Ninh Bình 3
Princeton 3
Salvador 3
San Juan 3
Santo André 3
Tây Ninh 3
Volta Redonda 3
Acalanes Ridge 2
Americana 2
Barbacena 2
Bauru 2
Belgrade 2
Belo Horizonte 2
Bình Dương 2
Campina Grande 2
Canoas 2
Cao Lanh 2
Caracas 2
Carapicuíba 2
Centenario 2
Ciudad del Este 2
Contagem 2
Dublin 2
Hortolândia 2
Iguape 2
Irecê 2
Jakarta 2
Juiz de Fora 2
Maceió 2
Marília 2
Medellín 2
Montreal 2
Moscow 2
Nha Trang 2
Paragominas 2
Pelotas 2
Petrolina 2
Piracicaba 2
Ponta Grossa 2
Portoviejo 2
Pouso Alegre 2
Quilicura 2
Quixadá 2
Recife 2
Ribeirão das Neves 2
Rio das Ostras 2
Totale 5.152
Nome #
Hashimoto's thyroiditis predicts outcome in intrathyroidal papillary thyroid cancer 681
A Prospective Multicenter Study Examining the Relationship Between Thyroid Cancer Treatment Outcomes and the Presence of Autoimmune Thyroiditis 441
The primary occurrence of BRAF(V600E) is a rare clonal event in papillary thyroid carcinoma. 348
The combined use of biological investigations, bio chromatographic and in silico methods to solve the puzzle of badge and its derivative's toxicity 296
Significance of RAS Mutations in Thyroid Benign Nodules and Non-Medullary Thyroid Cancer 283
Exposure to Bisphenol A increases malignancy risk of thyroid nodules in overweight/obese patients 282
Evolution of benign thyroid nodules under levothyroxine non-suppressive therapy 275
Thyroid nodules treated with percutaneous radiofrequency thermal ablation: A comparative study 242
BRAF mutation positive papillary thyroid carcinoma is less advanced when Hashimoto's thyroiditis lymphocytic infiltration is present 225
Human exposure to bisphenol AF and diethylhexylphthalate increases susceptibility to develop differentiated thyroid cancer in patients with thyroid nodules 198
Complete disappearance of liver metastases in a patient with iodine-refractory differentiated thyroid cancer subjected to sorafenib re-challenge 170
BRAF V600E associates with cytoplasmatic localization of p27kip1 and higher cytokeratin 19 expression in papillary thyroid carcinoma 155
GH provocative tests stimulate the growth in children with idiopathic short stature 138
Great veins invasion in follicular thyroid cancer: single-centre study assessing prevalence and clinical outcome 123
Kinase-inhibitors for iodine-refractory differentiated thyroid cancer: still far from a structured therapeutic algorithm 101
Survival Predictors of Radioiodine-refractory Differentiated Thyroid Cancer Treated With Lenvatinib in Real Life 92
Fibrous Variant of Hashimoto’s Thyroiditis as a Diagnostic Pitfall in Thyroid Pathology 90
Impact of long-acting octreotide in patients with early-stage MEN1-related duodeno-pancreatic neuroendocrine tumours 86
Papillary thyroid carcinoma with high percentage of BRAFV600E alleles have a higher recurrence rate 83
TSH modulation in advanced differentiated thyroid cancer: a continuous walk on the tightrope between prognostic stratification, adverse events, and levothyroxine bioavailability 82
Prognostic role of the CDNK1B V109G polymorphism in multiple endocrine neoplasia type 1 80
Cabozantinib in the Treatment of Neuroendocrine Neoplasms: Insights across Different Tumor Origins 60
Targeted therapy with kinase inhibitors in aggressive endocrine tumors 55
Preliminary data of VEGF-A and VEGFR-2 polymorphisms as predictive factors of radiological response and clinical outcome in iodine-refractory differentiated thyroid cancer treated with sorafenib 52
Fathoming the link between anthropogenic chemical contamination and thyroid cancer 52
Inibitori multichinasici nel trattamento del carcinoma differenziato tiroideo iodio-refrattario 50
Transarterial embolization (TAE) is equally effective and slightly safer than transarterial chemoembolization (TACE) to manage liver metastases in neuroendocrine tumors 49
Benign thyroid nodules with RAS mutation grow faster 48
Assessment and clinical implications of RANK/RANKL/OPG pathway as markers of bone tumor progression in patients with NET harboring bone metastases 48
A High Percentage of BRAFV600E Alleles in Papillary Thyroid Carcinoma Predicts a Poorer Outcome 40
Cell-Free DNA Analysis within the Challenges of Thyroid Cancer Management 40
Erratum to: Preliminary data of VEGF-A and VEGFR-2 polymorphisms as predictive factors of radiological response and clinical outcome in iodine-refractory differentiated thyroid cancer treated with sorafenib (Endocrine, (2017), 57, 3, (539-543), 10.1007/s12020-016-1200-6) 38
Sorafenib in advanced iodine-refractory differentiated thyroid cancer: efficacy, safety and exploratory analysis of role of serum thyroglobulin and FDG-PET. 36
Editorial: Papillary thyroid cancer: prognostic factors and risk assessment 35
Are RET/PTC Rearrangements in Benign Thyroid Nodules of Biological Significance? 33
RET/PTC rearrangement in benign and malignant thyroid diseases: a clinical standpoint 30
Radioiodide induces apoptosis in human thyroid tissue in culture 28
BRAF mutation in cytology samples as a diagnostic tool for papillary thyroid carcinoma 28
Impact of Dietary Supplements on Clinical Outcomes and Quality of Life in Patients with Breast Cancer: A Systematic Review 27
Combined biological therapy with lanreotide autogel and cabergoline in the treatment of MEN-1-related insulinomas 27
Chromogranin a as circulating marker for diagnosis and management of neuroendocrine neoplasms: More flaws than fame 27
Application of molecular biology of differentiated thyroid cancer for clinical prognostication 26
Detection of RET/PTC, TRK and BRAF mutations in preoperative diagnosis of thyroid nodules with indeterminate cytological findings. 26
Inhibition of Metalloproteinases-2, -9, and -14 Suppresses Papillary Thyroid Carcinoma Cell Migration and Invasion 25
Impact of cinacalcet hydrochloride in clinical management of primary hyperparathyroidism in multiple endocrine neoplasia type 1 24
Role of nutritional therapy on dietary habits and glycemic control in insulin-treated kidney transplant patients with diabetes 24
Interferon-γ inhibits integrin-mediated extracellular signal-regulated kinase activation stimulated by fibronectin binding in thyroid cells 23
Interferon-γ inhibits integrin-mediated adhesion to fibronectin and survival signaling in thyroid cells 22
Supplements in Oncology: Uses, Hurdles, Guidance, and Future Perspectives 22
Growing thyroid nodules with benign histology and RET rearrangement 22
Integrin–fibronectin interaction is a pivotal biological and clinical determinant in papillary thyroid carcinoma 21
The evolving field of kinase inhibitors in thyroid cancer 21
Total Thyroidectomy with Harmonic Scalpel Combined with Gelatin Thrombin Hemostatic: A Focus on the Elderly Population—A Multicentric Study 21
Unintentional recurrent laryngeal nerve injuries following thyroidectomy: Is it the surgeon who pays the bill? 20
BRAF V600E assessment by pyrosequencing in fine needle aspirates of thyroid nodules with concurrent Hashimoto’s thyroiditis is a reliable assay 20
Prevalence of RET/PTC rearrangement in benign and malignant thyroid nodules and its clinical application 20
Potential role of cinacalcet hydrochloride in sporadic primary hyperparathyroidism without surgery indication 20
Limitations of Chromogranin A in clinical practice 19
Germline polymorphisms of the VEGF pathway predict recurrence in nonadvanced differentiated thyroid cancer 19
Integrin–fibronectin interaction is a pivotal biological and clinical determinant in papillary thyroid carcinoma 18
High Growth Rate of Benign Thyroid Nodules Bearing RET/PTC Rearrangements 17
Second-line sunitinib as a feasible approach for iodine-refractory differentiated thyroid cancer after the failure of first-line sorafenib 17
Hepatic arterial embolization in patients with neuroendocrine tumors 15
Totale 5.736
Categoria #
all - tutte 8.379
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 8.379


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/20214 0 0 0 0 1 0 1 0 1 0 1 0
2021/20227 0 0 1 0 0 0 0 0 1 1 1 3
2022/202312 1 0 0 1 2 4 0 0 4 0 0 0
2023/20246 2 0 0 0 0 1 0 0 0 1 0 2
2024/20258 0 0 0 2 1 1 1 1 1 0 0 1
2025/20265.663 586 2.769 2.215 93 0 0 0 0 0 0 0 0
Totale 5.736